Enap tablets

Страна: Армения

Язык: английский

Источник: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Активный ингредиент:

enalapril (enalapril maleate)

Доступна с:

KRKA d.d.

код АТС:

C09AA02

ИНН (Международная Имя):

enalapril (enalapril maleate)

дозировка:

5mg

Фармацевтическая форма:

tablets

Штук в упаковке:

(20/2x10/) in blister

Тип рецепта:

Prescription

Статус Авторизация:

Registered

Дата Авторизация:

2017-02-10

тонкая брошюра

VOL:
I;
P: 99/456
SPC,
Labelin
1.3.1
JIHCTOK-BKll!l)J;hIW (O.llHOBpeMeHHo
Cpe.llCTBa)
'3HAN*
2,5
MR
TAOJJETKH
'3RAN*
5
MR TAOJLETKR
'3HAN·
10
MR TAOJJETKH
'3HAN·
20
MR TAOJLETKH
HHCTPYKUJoUIno
Me.llHU'HHCKOMY np'HMeHeH'H1OneKapCTBeHHoro
TOPROBOE
H31BAHHC
'3Han (Enap)
EX
r
E R T
_I_
J
!.
T A -
_d/2/ll._
_01_
_1/_
~-LI~
.~
...
T
_P//YrO/r/Y_
MELK,LLYHAP0.LLHOE HEN3TEHTOBAHHOE
HA3BAHHE Enalapril
JIEKAPCTBEUHASI
TOPM3
Ta6J1eTKH
2,5
Mf,
Ta6neTKH
5
Mf,
Ta6neTKH
10
Mf;
Ta6neTKH
20
Mf
EOCTAB Ka)l(JlaR Ta6J1eTKa CO.llep)l(lfT
2,5
Mf,
5
Mf,
10
Mr
Hmf
20
MT 3HananpwJa
ManeaTa.
Ta6neTKH
2,5
Mr
_BcnoMOZameJ7bHble_
_6l!U1ecm6a:_
HaTpHli
rHJlpoKap6oHaT,
naKT03a
MOHOrHJlpaT,
MaHCOBLI"
KpaXMan,
rHJlPOKcHIlpOITHJ1IleJ1J1lOn03a,
TanLK,
MafHHlI
CTeapaT.
T a611eTKH
5
Mr
_BcnoMozame,7bHble_
_6el/.leCm6a:_
HaTpHli
rHJlpoKap6oHaT,
naKT03a
MOHOnfJlpaT,
MaHcoBblR KpaxMan,
rIof.llpOKCnnpOmVIlleJUDOn03a,
Tan'bIC,MarHHJI
cTeapaT.
Ta6neTKlf
10
Mf
_BcnOiWOZameJlbHble_
_6l!U1ecm6a:_
HaTpHli
rHJlpOKap6oHaT,
naKT03a
MOHOrHJlpaT,
MaHCOBLI"
KpaxMan,
:lKene3a OKCH,llKpacHblH E
172,
TanI.K,
MarHJ.fJICTeapaT.
Ta6neTKH
20
Mr
_BcnOlWOZameJ7bHble 6eulecm6a:_
HaTpJ.fJl nf.llpOKap6oHaT,
_naKT03a_
MOHofHJlpaT,
MaHCOBhI"
KpaXMan,
:lKene3a OKCHJlKpacHbIH E
172,
)Kene3a OKCH,ll)KenTbIH
E 172,
TanbK,
MafHJ.fJI cTeapaT.
ONHCAHRE
Ta6neTKH
2,5
Mr:
KpyrJlble,
.llBOliKOBblnyKJIble,
co CKoweHHI.IM KpaeM Ta6neTKH,
6eJIoro
useTa.
Ta6neTKlf
5
Mf:
KpyrJ1'bIe,
IUIOCKlfe Ta6neTKlf,
6eJIoro
Hnlf
nO'lTH 6eJIOfO UBeTa,
co
CKomeHHLIMH
KpallMH H HaCe'IICOHRa O.llHOHcTopoHe.
Ta6neTKa MO)KeT 6LTTI. nO.lleneHa Ha paBHLTeqaCTH.
Ta6J1eTKH
10
Mr:
KpyrnLle,
rulOcKlfe
Ta6neTKH KpacHoBaTo
-
Kop",,"eBOfO
UBeTa,
co
CKOlUeHHLIM
KpaeM H HaCeqKOMHa OJlHOHcTopoHe,
C OT)lenLHLlMH BKpanneHHJJMH 6enofo
UBen
Ha nOBepxHocTH H
B Macce Ta6neTKH.
HaCe'lKa
He npe.llHa3HaqeHa .ll11l1pa3nOMa Ta6neTKH.
Ta6neTKH
20
Mf:
KpyrJl'ble,
nJlOCKHe Ta6neTKH CBeTno -
OpaH)KeBOrO UBeTa co CKOlUeHHblM KpaeM J.I
Hace'!
Kon Ha O)lHOMcTopoHe,
C OT)lenbHbIMH BKpalTJleHHlIMH 6enofo
UBen
Ha nOBepxHocTH H B Macce
Ta6neTKl

Характеристики продукта

1.3.1
Enalapril maleate
SPC, Labeling and Package Leaflet
AM
SmPCPIL164228_1
01.04.2021 – Updated: 01.04.2021
Page 1 of 15
1.
NAME OF THE MEDICINAL PRODUCT
Enap
®
2.5 mg tablets
Enap
®
5 mg tablets
Enap
®
10 mg tablets
Enap
®
20 mg tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 2.5 mg, 5 mg, 10 mg or 20 mg enalapril maleate,
which is equivalent to 1.9 mg,
3.8 mg, 7.6 mg or 15.3 mg enalapril.
Excipient with known effect:
2.5 mg tablets
5 mg tablets
10 mg tablets
20 mg tablets
lactose
61.7 mg
123.3 mg
118.4 mg
111.9 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet.
2.5 mg: white, round, biconvex, bevel-edged tablets.
5 mg: white to almost white, round, flat, bevel-edged tablets scored
on one side. The tablet can be
divided into equal doses.
10 mg: round, flat, red-brown, one side scored tablets with bevel edge
and individual white spots on
the surface and within the mass of tablets. The scoreline is not
intended to facilitate breaking of the
tablet for ease of swallowing or to divide it into equal halves.
20 mg: round, flat, light-orange, one-side scored tablets with bevel
edge, and individual white spots on
the surface and within the mass of tablets. The scoreline is not
intended to facilitate breaking of the
tablet for ease of swallowing or to divide it into equal halves.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
-
Treatment of hypertension
-
Treatment of symptomatic heart failure
-
Prevention of symptomatic heart failure in patients with asymptomatic
left ventricular
dysfunction (ejection fraction ≤ 35%)
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_Hypertension_
The initial dose is 5 mg to 20 mg, depending on the degree of
hypertension and the condition of the
patient. The drug should be taken once daily. In mild hypertension,
the recommended initial dose is 5
mg to 10 mg daily. Patients with a strongly activated
renin-angiotensin-aldosterone system, (e.g.
renovascular hypertension, salt and/or volume depletion, cardiac
decompensation or